Non-Current Assets
Operating Lease Right-of-Use Assets in Other Assets
Moderna Operating Lease Right-of-Use Assets in Other Assets decreased by 1.8% to $706.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.1%, from $752.00M to $706.00M. Over 5 years (FY 2020 to FY 2025), Operating Lease Right-of-Use Assets in Other Assets shows an upward trend with a 51.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2018
Last reportedQ1 2026May 1, 2026
Metric ID:
operating_lease_rou_assets_in_otherHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $104.00M | $115.00M | $142.00M | $132.00M | $122.00M | $113.00M | $121.00M | $117.00M | $130.00M | $765.00M | $713.00M | $697.00M | $775.00M | $784.00M | $759.00M | $752.00M | $750.00M | $738.00M | $719.00M | $706.00M |
| QoQ Change | — | +10.6% | +23.5% | -7.0% | -7.6% | -7.4% | +7.1% | -3.3% | +11.1% | +488.5% | -6.8% | -2.2% | +11.2% | +1.2% | -3.2% | -0.9% | -0.3% | -1.6% | -2.6% | -1.8% |
| YoY Change | — | — | — | — | +17.3% | -1.7% | -14.8% | -11.4% | +6.6% | +577.0% | +489.3% | +495.7% | +496.2% | +2.5% | +6.5% | +7.9% | -3.2% | -5.9% | -5.3% | -6.1% |
Range$104.00M – $784.00M
CAGR+49.7%
Avg YoY Growth+128.2%
Median YoY Growth+4.5%
Current Streak6 quarters decline
Operating Lease Right-of-Use Assets in Other Assets at Other Companies
Frequently Asked Questions
- What is Moderna's operating lease right-of-use assets in other assets?
- Moderna (MRNA) reported operating lease right-of-use assets in other assets of $706.00M in Q1 2026.
- How has Moderna's operating lease right-of-use assets in other assets changed year-over-year?
- Moderna's operating lease right-of-use assets in other assets decreased by 6.1% year-over-year, from $752.00M to $706.00M.
- What is the long-term trend for Moderna's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Moderna's operating lease right-of-use assets in other assets has grown at a 51.5% compound annual growth rate (CAGR), from $90.00M to $719.00M.